DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Meglumine antimoniate
Meglumine antimoniate
Trs
A Comparative Study of Aminosidine Sulfate
National Essential Medicine List of Afghanistan
World Health Organization Model List of Essential Medicines, 21St List, 2019
Pancreatic Toxicity As an Adverse Effect Induced by Meglumine Antimoniate Therapy in a Clinical Trial for Cutaneous Leishmaniasis
Is Paromomycin an Effective and Safe Treatment Against Cutaneous Leishmaniasis? a Meta-Analysis of 14 Randomized Controlled Trials
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: a Systematic Review
Tissue Distribution of Residual Antimony in Rats Treated with Multiple Doses of Meglumine Antimoniate
Perspectives of Antimony Compounds in Oncology
The Selection and Use of Essential Medicines
Drugs for Parasitic Infections (2013 Edition)
Antiprotozoal Compounds: State of the Art and New Developments F
WHO Drug Information Vol. 11, No. 3, 1997
Ve Duque Maria Etal INI 2019.Pdf
Revista6vol86v6 ING Layout 1
Tissue Distribution of Residual Antimony in Rats Treated with Multiple Doses of Meglumine Antimoniate
National Licensed Medicine List of Afghanistan
Access to Essential Drugs in Poor Countries a Lost Battle?
Top View
Toxicological Profile for Antimony
Therapeutic Efficacy Evaluation of Metronidazole and Some Antifungal
A Review of Current Treatments Strategies Based on Paromomycin for Leishmaniasis A.P.S
Pdf 331.71 K
In Vitro and in Vivo Activity of Meglumine Antimoniate Produced at Farmanguinhos-Fiocruz, Brazil, Against Leishmania (Leishmania
Leishmaniasis in the Americas. Treatment Recommendations
Comparing the Efficacy of Oral Chloroquine Versus Oral
Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: a Systematic Review
Pentavalent Antimonials: New Perspectives for Old Drugs
Manual for Case Management of Cutaneous Leishmaniasis in the WHO Eastern Mediterranean Region
Case Report: Combination Therapy with Liposomal Amphotericin B, N
Costs of Medicines in Current Use for the Treatment of Leishmaniasis
Comparison Between the Efficacy and Safety of Intralesional Sodium
Successful Treatment with Intralesional Meglumine Antimoniate in Recurrent Cutaneous Leishmaniasis: Case Report
National Essential Medicine List of Afghanistan
Antimony Toxicity
WHO Model List of Essential Medicines
Cross Discipline Team Leader Review
National Licensed Medicine List of Afghanistan
Antimony in Drinking-Water
The Selection and Use of Essential Medicines
Efficacy of Different Treatment Regimens of Marbofloxacin In
Safety and Effectiveness of Meglumine Antimoniate in the Treatment of Ethiopian Visceral Leishmaniasis Patients with and Without HIV Co-Infection
Canine Leishmaniasis - an Update 4-19 Maurice Roze
Use of the Intramuscular Route to Administer Pentamidine Isethionate
Visceral Leishmaniasis Treatment, Italy
Kinetoplastida: New Therapeutic Strategies Croft S.L.*
The Need for New Antiparasitic Agents
Miltefosine for Bolivian Cutaneous Leishmaniasis
The Selection and Use of Essential Medicines
American Cutaneous Leishmaniasis Caused by Leishmania (Viannia) Braziliensis Resistant to Meglumine Antimoniate, but with Good Response to Pentamidine: a Case Report